Psychopharmacology

New evidence-coupled with advances in molecular biology-has afforded an unparalleled opportunity to move toward identifying potential new treatments for schizophrenia.

This method of administration can mitigate the psychotomimetic and dissociative effects of ketamine.

How do the 3 FDA-approved dopamine receptor partial agonists for the treatment of MDD and other psychiatric disorders stack up against each other?

A new finding that may help optimize the treatment of major depressive disorder.

Before flibanserin, there were no FDA-approved treatments for hypoactive sexual desire disorder. The authors clarify the intricacies of an HSDD diagnosis and discuss implications for treatment.

For all its popular appeal, the science that has emerged on cannabis use does not look good--especially for the teenage brain.

Psychiatrists can provide significant support and insight to patients who are now coming to campus with a wide array of mental health challenges.

This article summarizes clinically relevant advances in the psychiatric care of women during and after pregnancy, including recent changes in how the FDA classifies pregnancy risk for medications, and best practices in perinatal psychopharmacology.

Information about the performance of clozapine compared with other treatment strategies in usual practice may impact on its use in routine clinical settings. Here: findings from US national Medicaid data in a cohort of patients with treatment-resistant schizophrenia.

Researchers conducted a clinical trial comparing light therapy with antidepressant monotherapy. Here's what they found.

What is behind the glaring lack of controls over prescription drug costs, even for everyday medications?

Intended for short-term use, this treatment is associated with specific diagnostic and symptom characteristics, with anhedonia being a stand-out.

If serotonin was once American psychiatry’s “high school crush,” the field now appears wedded to a more mature model of biological and psychosocial understanding.

This article reviews a wide array of medicolegal, risk management, regulatory, and forensic mental health issues in the older population, which is growing at an accelerated rate.

Food taken with which atypical antipsychotics discussed here may increase absorption?

Flibanserin is a breakthrough. We will finally be able to talk to women with hypoactive sexual desire disorder about a treatment that has FDA approval.

Treatment with a selective estrogen receptor modulator in adjunct to antipsychotics was associated with improvements in attention and memory in men and women with schizophrenia in a recent trial.

Do cholinesterase inhibitors lead to weight loss in older adults with dementia? Here's a wrap up of a large study of patients in a real-world setting who had newly started these medications.

Details here about a protocol for opioid abusers and the mentally ill that helped avoid deaths from drug overdose after psychiatric hospitalization.

Dose escalation is often applied in the management of psychosis when patients do not initially respond to therapy, but a recent study brings this strategy under question.

Experts summarize data on the role of inflammation in psychiatric disorders, emphasizing that evidence for anti-inflammatory treatment for mood disorders is limited, and mixed.

A recent study from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) investigated the genetics of the auditory event-related potential, a putative psychosis biomarker.

The authors explore ways to address aggression in clinical practice and examine the potentially dangerous impulsivity-violence link across a broad range of conditions.

The challenges of recognizing behaviors such as hypersexuality, gambling, and excessive buying in Parkinson disease are discussed, as are ways to address them while still managing the underlying condition.

Internet-based CBT has shown promise to improve access to therapy for patients with OCD, which is associated with a profoundly diminished quality of life and social isolation.